Use of Laser in Treatment of Premalignant Skin Conditions. | [Pakistan Journal of Biotechnology • 2018]

Author(s):

1. Sahib Neamah AbdulWahid: Faculty of Education for Girls, Physics Department, University of Kufa, Iraq

2. Kadhum Shabba: Faculty of medicine, University of Kufa, Iraq

3. Bushra Ghaly Yousif: Faculty of Education for Girls, Physics Department, University of Kufa, Iraq

4. Arowa abdalhusain: Faculty of Medicine, Dermatology Department, University of Al Muthanna,

5. Nasser Ghaly Yousif: Faculty of Medicine, Medicine Department, University of Al Muthanna, Iraq. E. mail:,

Abstract:

There are various treatment procedures that are used the laser beam in the medical applications especially in the treatment of skin diseases. Some of them are utilized for cosmetic surgery, inflammatory tissue and some for premalignant skin conditions. According to the laser generation systems, there are several types of laser which are used in the medical application such as CO2, Er:YAG and the rest laser types. Almost, all of them are succeed in these applications and distinguished results are achieved. The aim of this study is to investigate the feasibility of using laser beam for treatment of the premalignant skin conditions within three types of laser have been used: CO2 laser, Er:YAG and Semiconductor laser (Diode laser). Different types of premalignant skin conditions such as Keratoacanthoma, Dysplastic nevus, Marjolin's ulcer and Xeroderma pigmentosum have been treated in this paper by those laser types.

Page(s): 763-767

DOI: DOI not available

Published: Journal: Pakistan Journal of Biotechnology, Volume: 15, Issue: 3, Year: 2018

Keywords:

Keywords are not available for this article.

References:

[1] AbdelaalM.,Al-liethyI.,FewerComplications,J.Plast, 2006.Treatment of Medium-Size Congenital Melanocytic Nevi (CMN) by New Combined Laser Therapy: Better Results,Recstr. Surg 30 69 -74

[2] Abdul Wahid S . and N.,Ali, 2016.Efficacy and Safety of 532nm and 1064nmQswitched Nd: YAG Laser Treatment of Pigmentation,AENSI Publication 6 56 -69

[3] AzadgoliB.,R.Y.Bake, 2016.Laser application in surgery,Ann Transl. Med 452 -

[4] Cantarelli M. and M.M. Schubert,Niccoli-FilhoW., 2006.Surgical treatment of erythroleukoplakia in lower lip with carbon dioxide laser radiation,Lasers Med. Sci 21 181 -4

[5] FrazierMS., 2016.by Saunders, an imprint of Elsevier Inc,ISBN: 978-1-4377-2408- 0 -

[6] HantashB.M.,StewartDB.,Z., 2006.,Facial Resurfacing for Nonmelanoma Skin Cancer Prophylaxis. American Medical Association 142 976 -982

[7] HatzisGP. And R. Finn, 2000.Marjolin's ulcer: a review of the literature and report of a unique patient treated with a CO2 laser,J. Oral Maxillofac Surg 65 2099 -2105

[8] Iyer S1. , Friedli,A. , Bowes,L. , Kricorian,G.,R.E.Fitzpatrick, 2004.Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer,Lasers Surg. Med 34 114 -9

[9] KaplanI.,XerodermaPigmentosum, 2012.,Laser Ther 21 13 -14

[10] LeeEH.,NehalKS,J.J.Disa, 2010.Dermatology Service and the Plastic and Reconstructive Surgery Service, Memorial Sloan-Kettering Cancer Center,Plast Reconstr. Surg 125 188e -198e

[11] Mohseen H., 2017.The effects of laser radiation on viscosity (pcv) of blood,Pak. J. Biotechnol 14 477 -479

[12] Ramu G.,A.Jayanthi, 2017.A review on precision medicine and its advantages,Pak. J. Biotechnol 14 515 -519

[13] Silfvast W. , Laser,Fundamentals, 2004., -

[14] Slimani H. , Zhai,Y.L. , Yousif,N.G., 2014.Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemia,Crit. Care 18 527 -

[15] SongK.,Future, 2017.,and Clinical Application 6 1 -4

[16] Thiele J. , Ziemer,M. , Fuchs,S.,P.Elsner, 2004.-fluorouracil and Er: YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg,Dermatol. Surg 30 1556 -60

[17] Tsuchimoto Y. , Hwang,R. , Chen,S.,X., 2015.LiuI, IFN-γ-promote innate defense against gonococcal infection via producing B cells,American Journal of BioMedicine 3 295 -312

[18] YousifNG.,Al-AmranFG,LeeJ.,AdrienneJ., 2013.32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer,Cytokine 61 223 -7

[19] Yousif N.G.,F.G., 2011.Al-amran, Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice,BMC Cardiovasc. Disord 11 -

Citations

Downloads

Views